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Introduction
The opioid crisis besetting every region of the United
States directly affects more than just those who use
substances. For a pregnant woman, a consequence of
substance use can be neonatal abstinence syndrome
(NAS)—withdrawal symptoms experienced by the
newborn (see Box 1).
NAS is on the rise in New Hampshire, but prenatal
care for the mother can reduce or eliminate the risk.
Newborns who are treated recover, yet mothers using
opioids are often using other substances and confronting behavioral health issues which complicate recovery.
This brief analyzes inpatient hospital discharge
data (2012–2015) to assess the prevalence of NAS in
New Hampshire; describes one hospital’s successful
program for treating pregnant women and newborns;
discusses how comprehensive and coordinated care
and home visiting services provided through community based organizations can support new mothers
and families; and discusses how a recent change to
New Hampshire law intended to support child
protection may be having unintended consequences.

Opioid Drug Use and NAS
in New Hampshire
Drug overdose deaths are on the rise in New Hampshire.
In 2016, the state medical examiner reported 488 deaths
from drug overdoses, up from 192 just four years
earlier (Figure 1).1 Overdose deaths among women
nearly tripled between 2008 and 2016, from 52 to 149.
However, because the incidence of drug overdose death
among men grew at a faster pace, women represented
a smaller proportion of overdose deaths in 2016 (31
percent) than in 2008 (44 percent).2
Opioid-related emergency department visits can be
used to estimate opioid use. In 2016, there were 2,632
female and 3,452 male visits,3 and they were most

prevalent among 20–29-year-olds and 30–39-year-olds,
the typical child-bearing years for women.
An increase in maternal drug use accounts for a
rise in the number of newborns diagnosed with NAS.
The rate of NAS in the United States rose from 1.2 per
every 1,000 hospital births in 2000 to 5.8 per 1,000
in 2012,4 leading many to call perinatal opioid use a
national public health crisis.5 In New Hampshire, NAS
has increased fivefold since the early 2000s (Figure 2).
In 2015, 269 infants were diagnosed with NAS, compared to 52 in 2005.6 This number may be an underestimate, because hospitals may report NAS differently
depending on provider documentation and coding
of diagnosis, and also issues of data quality.7 Figure 2
also shows that the rate of NAS births per 1,000 live
hospital births reached 24.4 per 1,000 in 2015. In other
words, at least 2.4 percent of live New Hampshire
births in 2015 were diagnosed with NAS.
In 2015, New Hampshire newborns diagnosed with
NAS remained in the hospital on average twelve days,
owing to some needing monitoring and care while
they were weaned off opiates, compared to three days
for newborns not born exposed. However, not all
newborns with NAS needed intensive services, and 41
percent were able to leave the hospital within five days.
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FIGURE 1. NUMBER OF DEATHS FROM DRUG OVERDOSES IN NEW HAMPSHIRE,
BY SEX, 1995–2016

Source: Office of the Chief Medical Examiner, Department of Justice. Number of deaths for men and women do
not add to total due to missing data by sex.

FIGURE 2. NEONATAL ABSTINENCE SYNDROME AMONG NEW HAMPSHIRE
INFANT DISCHARGES, 2000–2015

Source: New Hampshire inpatient hospital discharge data, 2000–2015. 2000–2011 data published in Maternal
and Child Health, “Neonatal Abstinence Syndrome” (Concord: New Hampshire Department of Health and Human
Services); 2012–2015 data analyzed by the author. The 2000–2011 data include infant discharges from both
in-state and out-of-state hospitals among New Hampshire residents. Due to data constraints, the 2012–2015
data include discharges from only in-state hospitals among New Hampshire residents.

Early Successes in
Addressing NAS
Hospitals are responding to the
increased prevalence of NAS in
different ways. Some offer prenatal
comprehensive and coordinated care,
including medication-assisted treatment, while others have instituted
postnatal infant cuddling programs,
since skin-to-skin contact is important for infants during withdrawal

and recovery. Since 2015 (the time
of data collection), several New
Hampshire hospitals have instituted
protocols for NAS intervention that
have shortened the length of stay for
newborns with NAS.
The Dartmouth-Hitchcock Medical
Center (DHMC) launched one of the
first programs in New Hampshire,
the Moms in Recovery program, in
2013 to address the need for access to
treatment among pregnant women

who were using opiates. Moms in
Recovery uses an integrated model
to provide outpatient medicationassisted treatment, maternity care,
maternal behavioral health care,
referrals to community services, and
case management. Participants attend
group treatment sessions focused
on addiction treatment and education and receive individual visits for
medication, individual therapy, case
management, and prenatal care.
DHMC reports that its program
has been successful in achieving
positive maternal and neonatal
outcomes, and in some cases the
birth outcomes are comparable to
the overall population of births. For
example, fewer than 25 percent of
infants born to DHMC Moms in
Recovery participants require treatment for NAS; the length of stay for
neonates requiring treatment has
declined by three days since 2013,
and about 80 percent of program
participants initiate breastfeeding.8
In 2015, 7.8 percent of newborns
to New Hampshire residents at
DHMC were diagnosed with NAS,
a higher proportion than the statewide average of 2.4 percent,9 but
NAS births at DHMC had a shorter
length of stay compared with other
New Hampshire hospitals—8.3
versus 13.3 days.10 Although not
conclusive, these data suggest that
DHMC’s programs are reducing
the length of the hospital stay for
newborns with NAS.
NAS births are more costly on
average than other births, likely
owing to longer hospital stays.11
In 2015, the total discharge amount
for all births coded with an NAS
diagnosis in New Hampshire averaged $33,700, compared to $7,800
for those not diagnosed with NAS.12
Medicaid covered 78 percent of
NAS births in 2013.13
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Increase and Target
Services to Address NAS
Statewide
During pregnancy, women who are
drug dependent often voice motivation to stop using drugs and to seek
treatment.14 Thus, pregnancy provides an opportune time for health
care providers and hospitals to initiate services and provide referrals,
and there are a variety of options.
Community-based nonprofit service organizations15 are at the front
line of the opioid crisis, providing
services on a voluntary basis to
families in need. Services support
and promote family health and
well-being through education and
prevention, often in collaboration
with other social service agencies
and local public and private organizations. Programs offered typically
include health education, safety,
and injury prevention; assistance
with enrollment in health insurance,
nutrition programs, or child care
payment assistance programs; family mentoring, parenting, and child
development education; domestic
violence prevention and interventions services; and home visiting.
Home visiting has been shown to
improve maternal and infant health,
increase children’s school readiness and safety, and improve family
self-sufficiency.21 Two state-wide
programs operate on a contract
basis through community-based
nonprofit service organizations:
the Maternal Infant and Early
Childhood Home Visiting Program
(MIECHV), which is under the
Maternal and Child Health Section
of the New Hampshire Department
of Health and Human Services;
and Comprehensive Family
Support Services (CFSS), under the
Department of Children, Youth,
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Box 1: What Is NAS?
Neonatal abstinence syndrome is a set of conditions occurring when a
newborn experiences withdrawal symptoms after birth from drug exposure before birth. It is most often caused by opioids.16 Symptoms appear
shortly after birth and include irritability, problems feeding, watery stools,
overly toned muscles, tremors, seizures, and/or breathing problems.17
Data from prenatal care and treatment programs show that birth outcomes are better when pregnant women who are using drugs participate
in prenatal care and undergo substance use treatment. Negative birth
outcomes such as neonatal withdrawal, prematurity, fetal demise, and
low birth weight are reduced when medication-assisted treatment, such
as administration of methadone or buprenorphine, is prescribed during
pregnancy.18 NAS can be treated or managed in the hospital after birth,
and infants who are treated recover. The long-term effects of prenatal
exposure are difficult to determine because of the challenge of isolating
the independent effect of prenatal opiate exposure, prenatal co-exposure
to other substances (tobacco, alcohol, other illicit drugs), and behavioral
health and environmental factors (mental health, poverty, poor prenatal
care).19 While the research is inconsistent as to the long-term consequences of NAS, studies consistently show that children diagnosed with
fetal alcohol syndrome demonstrate delays in motor functions, poor
coordination, delays in fine motor skills, and cognitive disability that
persists into childhood.20
and Families. A small portion of the
CFSS home visiting program is paid
for by Medicaid.
MIECHV uses the Healthy
Families America model, a researchbased voluntary home visiting
program that targets families most
at risk of child maltreatment and
adverse childhood experiences.
Many of the families receiving
MIECHV services struggle with
substances: an evaluation of New
Hampshire’s Healthy Families
America found that 37 percent
of caregivers served by the program were assessed as “known or
suspected of substance misuse.”22
Families voluntarily enroll in services prenatally or within two weeks
after a child’s birth, and services
span up to the child’s third birthday
with the goal of promoting healthy
child development and preventing
child abuse and neglect. In 2016,

MIECHV served 325 families at
11 sites, for a total of 4,639 home
visits.23 It is important to note that
in October 2017 Congress let the
MIECHV program expire.
Families with a child under 21
are eligible to participate in CFSS
voluntary services, which include
home visiting and other programs
offered by community-based
nonprofit service organizations.
Families voluntarily request services, and a service plan is initiated.
In 2015, 1,048 New Hampshire
families participated in CFSS, with
3,430 family members served,
including 1,926 children.24
For those who are eligible, CFSS
voluntary home visiting services can
be charged to the Medicaid home
visiting program, Home Visiting New
Hampshire, which has strict eligibility
guidelines. All mothers with infants
diagnosed with NAS are eligible, as
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long as they are Medicaid recipients,
first-time mothers, and under the
age of 21 enrolling in the program
no more than two weeks after the
child’s birth. Services can be provided
up to the child’s first birthday. Many
families are likely not aware of these
services because hospitals typically
give referrals for outside services at
discharge, and providers may shy
away from referrals for services that
are associated with the Department
of Children, Youth, and Families.
Moreover, Medicaid’s strict homevisiting guidelines translate into
few families being eligible for and
enrolling in the program. Loosening
the age restriction, allowing home
visits at the time of any birth, and
lengthening the signup period would
expand access to more families.
Working with hospitals, maternal
health care providers, and pediatricians to encourage referrals to home
visiting for newborns diagnosed with
NAS and their families could be an
important first step in ensuring continued child health. Offering pre- and
postnatal home visits to all families
could reduce stigma and go a long
way toward helping all new parents in
the first days home with a new baby.

Challenges to Addressing
NAS Statewide
Pregnant women are reluctant to
disclose their opioid use because
of the stigma associated with using
substances, especially while pregnant, and because of the fear that a
provider will report their substance
use to Child Protective Services,
resulting in their child being taken
away and their parental rights terminated.25 Yet mothers who do not
disclose suffer in silence and do not
get the care and services they need,
and their newborns have longer,
harder recoveries in the hospital.

In order to address NAS, legislators,
advocates, and health care providers
are calling for a shift away from punitive attitudes toward treatment in an
effort to reduce shame and encourage compliance among pregnant
women. A successful approach to this
problem will be one that treats both
the mother and the newborn with
comprehensive and coordinated care,
provides home visiting and other services to build confidence in parenting
and to spot issues before they spiral
into problems, and has a supportive
peer and community network. Yet,
New Hampshire also needs to ensure
that children are protected from
harm. Parental drug use endangers
children’s health and safety in the
short and long term. Children who
face adverse childhood experiences
such as parental addiction and drug
use have an elevated risk of using
drugs at age 14 and of continuing that
use into adulthood.26

Unintended Consequences
of Policy Change
In an effort to give the Department of
Children, Youth, and Families discretion and a legal basis for intervention
before harm occurs, in June 2016
New Hampshire amended its Child
Protection Act to create “a rebuttable
presumption that the child’s health
has suffered or is very likely to suffer
serious impairment” from a parent’s
drug use and so shifts the responsibility to parents to provide evidence of
their compliance with drug use treatment.27 A pregnant woman could use
participation in medication-assisted
treatment as evidence of compliance.
The bill does not conclude that a parent is neglectful if abusing drugs, nor
does it require departmental involvement or mandate removal of a child.
The stated intent is to give the department discretion and to encourage

treatment as a way to promote the
unity of the family when possible.28
However, there is persuasive anecdotal evidence of a misunderstanding of the intent of the law by parents
and within the health care, social service, and court systems. This confusion surrounds the interpretation of
mandatory reporting of child neglect
to the Department of Children,
Youth, and Families. Unintended
consequences may include a chilling
effect on women seeking prenatal
care, their willingness to disclose
during pregnancy, and reporting
by providers. Any of these consequences are detrimental to newborns
if pregnant women do not get the
treatment and care they need. More
research is needed to determine
how the law has been interpreted by
parents and professionals and, in the
wake of those findings, identify steps
to clarify any misinterpretation.

Conclusions
In 2015, 2.4 percent of New
Hampshire births were diagnosed
with NAS, and that number is projected to rise, with implications for
early intervention programs, early
education programs, and primary
schools. Children born drug-exposed
are at increased risk for behavioral
health problems, especially if their
parents continue using. Pregnancy
is a time to reach out to mothers, as
they are more receptive to services
and making a change. Reaching out
when their children are young to initiate treatment, provide services, and
shore up community supports within
a coordinated care and case management framework can be in the best
interest of the child’s health and safety.
Yet, mothers using opioids are often
also using other substances, including alcohol, cigarettes, marijuana,
and other illicit drugs, and are often
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confronting issues related to mental
health, poverty, homelessness, and/
or domestic violence—all of which
complicate recovery. Policies and
programs should not consider opioid
addiction in isolation, but rather as
one interconnected symptom within
a larger context. Both alcohol and
tobacco use during pregnancy have
proven negative health consequences
for children, and the adverse effects
on children are magnified when combined with opiates. Getting mothers
on a path to recovery is a formidable
challenge facing our state, but one
that ultimately will help children and
promote family unity.

Data
All hospitals licensed by the New
Hampshire Department of Health
and Human Services (DHHS) are
required by law to report patientlevel discharge information to DHSS.
Information collected includes, but
is not limited to, hospital, patient
demographic characteristics, admission type, admitting diagnosis,
procedure codes, length of stay, primary payer, and total discharge cost
received from the thirty-two reporting hospitals. The 2000–2011 data
come from the DHHS Maternal and
Child Health publication, “Neonatal
Abstinence Syndrome,” and include
infant discharges from both in-state
and out-of-state hospitals among
New Hampshire residents. Due to
data constraints, the 2012–2015
data include discharges among
only in-state hospitals among New
Hampshire residents. For consistency
in the trend line, we use the methodology employed by Maternal and
Child Health (2015) and Patrick et
al. (2015), which includes all infants
under 1 coded with a NAS diagnosis
in the discharge data. For comparisons across hospitals, we include newborns coded with a NAS diagnosis in
the discharge data.
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